Loss to Follow-Up: Patients with Type 1 Diabetes During the SARS-CoV-2 Pandemic.


Journal

Pediatric annals
ISSN: 1938-2359
Titre abrégé: Pediatr Ann
Pays: United States
ID NLM: 0356657

Informations de publication

Date de publication:
Jul 2024
Historique:
medline: 1 7 2024
pubmed: 1 7 2024
entrez: 1 7 2024
Statut: ppublish

Résumé

The SARS-CoV-2 (severe acute respiratory syndrome related coronavirus 2) pandemic revealed many flaws in our health care system. This review aims to explore the significance of loss to follow-up on patients with type 1 diabetes during the pandemic, the morbidity and mortality associated, and strategies to prevent loss to follow-up or to re-engage patients in longitudinal care.

Identifiants

pubmed: 38949871
doi: 10.3928/19382359-20240502-04
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e254-e257

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH